BeOne Medicines (ONC) EBT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -148.52% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 71.54% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.15% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -79.57% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 9,460.35% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,140.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,140.26% |
| Dec 31, 2025 | 274.86% |
| Sep 30, 2025 | 249.70% |
| Jun 30, 2025 | 193.99% |
| Mar 31, 2025 | 108.59% |
| Dec 31, 2024 | 75.67% |
| Sep 30, 2024 | -142.86% |
| Jun 30, 2024 | 71.18% |
| Mar 31, 2024 | 27.75% |
| Dec 31, 2023 | 18.61% |
| Sep 30, 2023 | 141.60% |
| Jun 30, 2023 | 34.10% |
| Mar 31, 2023 | 20.01% |
| Dec 31, 2022 | 28.89% |
| Sep 30, 2022 | -27.28% |
| Jun 30, 2022 | -16.03% |
| Mar 31, 2022 | -780.92% |
| Dec 31, 2021 | -25.74% |
| Sep 30, 2021 | 0.45% |
| Jun 30, 2021 | -42.27% |
| Mar 31, 2021 | 117.02% |
| Dec 31, 2020 | -26.72% |
| Sep 30, 2020 | -39.49% |
| Jun 30, 2020 | -302.97% |
| Mar 31, 2020 | -116.88% |
| Dec 31, 2019 | -38.18% |
| Sep 30, 2019 | -115.14% |
| Jun 30, 2019 | 47.96% |
| Mar 31, 2019 | -54.38% |
| Dec 31, 2018 | -191.69% |
| Sep 30, 2018 | -226.91% |
| Jun 30, 2018 | -166.35% |
| Mar 31, 2018 | -115.15% |
| Dec 31, 2017 | -149.31% |
| Sep 30, 2017 | 422.96% |
| Jun 30, 2017 | -152.11% |
| Mar 31, 2017 | -129.74% |
| Dec 31, 2016 | -253.87% |
| Sep 30, 2016 | -152.64% |
| Jun 30, 2016 | -325.26% |
| Mar 31, 2016 | -115.01% |